Cationic CaMKII Inhibiting Nanoparticles Prevent Allergic Asthma
© 2017 American Chemical Society. Asthma is a common lung disease affecting over 300 million people worldwide and is associated with increased reactive oxygen species, eosinophilic airway inflammation, bronchoconstriction, and mucus production. Targeting of novel therapeutic agents to the lungs of p...
Saved in:
Main Authors: | Angie S. Morris, Sara C. Sebag, John D. Paschke, Amaraporn Wongrakpanich, Kareem Ebeid, Mark E. Anderson, Isabella M. Grumbach, Aliasger K. Salem |
---|---|
Other Authors: | University of Iowa |
Format: | Article |
Published: |
2018
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/41841 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
CaMKII phosphorylates collapsin response mediator protein 2 and modulates axonal damage during glutamate excitotoxicity
by: Hou, S.T., et al.
Published: (2014) -
Synthetically lethal nanoparticles for treatment of endometrial cancer
by: Kareem Ebeid, et al.
Published: (2019) -
Development of DNA vaccines for allergic Asthma
by: HUANG FU TAO QI
Published: (2011) -
ALLERGIC ASTHMA IN SINGAPORE CHINESE – EPIDEMIOLOGY AND GENETICS
by: SIO YANG YIE
Published: (2020) -
Size-dependent cytotoxicity of copper oxide nanoparticles in lung epithelial cells
by: Amaraporn Wongrakpanich, et al.
Published: (2018)